Dr. Timmons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-2200Fax+1 215-349-5864
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
Certifications & Licensure
PA State Medical License 2010 - 2013
Publications & Presentations
PubMed
- 9 citationsSuppression of hPOT1 in Diploid Human Cells Results in an hTERT-Dependent Alteration of Telomere Length DynamicsRichard Possemato, Jamie C. Timmons, Erica L. Bauerlein, Naoya Wada, Amy Baldwin
Molecular Cancer Research. 2008-10-01 - 135 citationsCancer-Associated PP2A Aα Subunits Induce Functional Haploinsufficiency and TumorigenicityWen Chen, Jason D. Arroyo, Jamie C. Timmons, Richard Possemato, William C. Hahn
Cancer Research. 2005-09-15 - 9 citationsE2F-Dependent Repression of Topoisomerase II Regulates Heterochromatin Formation and Apoptosis in Cells with Melanoma-Prone MutationWan Jiao, Huei-Min Lin, Jamie C. Timmons, Akhilesh K. Nagaich, Shu-Wing Ng
Cancer Research. 2005-05-15
Press Mentions
Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALSSeptember 7th, 2022- Amylyx Pharmaceuticals Announces Outcome of FDA Advisory Committee Meeting on AMX0035 for the Treatment of ALSMarch 30th, 2022
‘Non Responders’ Need to Try Harder When Exercising, Study SuggestsNovember 29th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
